MENU
MRKR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Marker Therapeutics (MRKR) Ownership - Who owns Marker Therapeutics?

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications... Show more

Profile

Industry
Other Consumer Services
Address
2450 Holcombe Boulevard
Phone
+1 713 400-6400
Employees
5
Web
https://www.markertherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
22.84M
P/E Ratio
N/A
Total Cash
14.92M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.79
Dividend Yield
N/A
Total Cash/Share
0.89
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
MRKR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of cell based immune therapeutics and vaccines for cancer treatment

Industry Biotechnology

Profile
Details
Industry
Other Consumer Services
Address
2450 Holcombe Boulevard
Phone
+1 713 400-6400
Employees
5
Web
https://www.markertherapeutics.com